| Henry Vandenhazel, | |
|
934 S Main St, Layton, UT 84041-7135 | |
| (801) 773-7060 | |
| Not Available |
| Full Name | Henry Vandenhazel |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 16 Years |
| Location | 934 S Main St, Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568478410 | NPI | - | NPPES |
| 870430116009 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7069547-3501 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davis Behavioral Health Inc | 7416861919 | 44 |
News Archive
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
MarkMonitor®, the global leader in enterprise brand protection, today released the company's latest Brandjacking Index®, which finds a parallel online system of pharmaceutical supply and demand fueled by continued growth in listings for pharmaceuticals on business-to-business (B2B) exchange sites as well as increased traffic to illicit pharmacies. The report also reveals a growth in pharmaceutical brandjacking for popular drug brands.
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Investigators for NHLBI's Cardiovascular Health Study compared the two measures of kidney function, cystatin-C and the standard test creatinine, as predictors of death from all causes, death from cardiovascular causes, and incidence of heart attack and stroke among 4,637 elderly participants in the study.
The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.
› Verified 7 days ago
| Entity Name | Davis Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770641672 PECOS PAC ID: 7416861919 Enrollment ID: O20031118000909 |
News Archive
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
MarkMonitor®, the global leader in enterprise brand protection, today released the company's latest Brandjacking Index®, which finds a parallel online system of pharmaceutical supply and demand fueled by continued growth in listings for pharmaceuticals on business-to-business (B2B) exchange sites as well as increased traffic to illicit pharmacies. The report also reveals a growth in pharmaceutical brandjacking for popular drug brands.
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Investigators for NHLBI's Cardiovascular Health Study compared the two measures of kidney function, cystatin-C and the standard test creatinine, as predictors of death from all causes, death from cardiovascular causes, and incidence of heart attack and stroke among 4,637 elderly participants in the study.
The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Henry Vandenhazel, 934 S Main St, Layton, UT 84041-7135 Ph: (801) 773-7060 | Henry Vandenhazel, 934 S Main St, Layton, UT 84041-7135 Ph: (801) 773-7060 |
News Archive
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
MarkMonitor®, the global leader in enterprise brand protection, today released the company's latest Brandjacking Index®, which finds a parallel online system of pharmaceutical supply and demand fueled by continued growth in listings for pharmaceuticals on business-to-business (B2B) exchange sites as well as increased traffic to illicit pharmacies. The report also reveals a growth in pharmaceutical brandjacking for popular drug brands.
Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.
Investigators for NHLBI's Cardiovascular Health Study compared the two measures of kidney function, cystatin-C and the standard test creatinine, as predictors of death from all causes, death from cardiovascular causes, and incidence of heart attack and stroke among 4,637 elderly participants in the study.
The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.
› Verified 7 days ago
Kelley Diane Irmen, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Michele Tanner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Jennifer Lynn Forbes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
John David Larsen, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Curtis M. Tesch, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Alison Coburn, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1660 W Antelope Dr Ste 320, Layton, UT 84041 Phone: 801-773-4840 | |
Brady D Olsen, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 |